IgG4 can induce an M2-like phenotype in human monocyte-derived macrophages through FcγRI

• Published in: mAbs Vol. 6; no. 6; pp. 1377 - 1384
• Main Authors: Swisher, Jennifer FA, Haddad, Devin A, McGrath, Anna G, Boekhoudt, Gunther H, Feldman, Gerald M
• Format: Report
• Language: English
• Published: Taylor & Francis 02.11.2014
• Subjects: alternatively activated M2 macrophage; Fc gamma receptors; IgG4; immune complex; monocyte-derived macrophage
• ISSN: 1942-0862; 1942-0870
• DOI: 10.4161/19420862.2014.975657

Antibodies evoke cellular responses through the binding of their Fc region to Fc receptors, most of which contain immunoreceptor tyrosine-based activation motif domains and are thus considered "activating." However, there is a growing appreciation of these receptors for their ability to deliver an inhibitory signal as well. We previously described one such phenomenon whereby interferon (IFN)γ signaling is inhibited by immune complex signaling through FcγRI. To understand the implications of this in the context of therapeutic antibodies, we assessed individual IgG subclasses to determine their ability to deliver this anti-inflammatory signal in monocyte-derived macrophages. Like IgG1, we found that IgG4 is fully capable of inhibiting IFNγ-mediated events. In addition, F(ab')2 fragments that interfere with FcγRI signaling reversed this effect. For mAbs developed with either an IgG1 or an IgG4 constant region for indications where inflammation is undesirable, further examination of a potential Fc-dependent contribution to their mechanism of action is warranted.